We are live on ! Find out more
DIG

Dauntless Investment Group Portfolio holdings

AUM $151M
1-Year Est. Return 76.14%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+76.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
+$25.1M
Cap. Flow
+$25M
Cap. Flow %
16.54%
Top 10 Hldgs %
81.2%
Holding
96
New
30
Increased
14
Reduced
23
Closed
27

Sector Composition

1 Healthcare 14.59%
2 Consumer Staples 4.5%
3 Real Estate 1.4%
4 Energy 1.15%
5 Financials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEF icon
1
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$78.7M 52.11%
+824,700
New +$79.3M
KWEB icon
2
CALL
KraneShares CSI China Internet ETF
KWEB
$5.32B
$10.7M 7.08%
376,400
+361,000
+2,344% +$11.8M
XLY icon
3
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
$8.5M 5.63%
+78,000
New +$9.12M
IWM icon
4
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$7.04M 4.66%
+28,400
New +$7.33M
ASHR icon
5
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.29B
$4.03M 2.67%
123,400
+2,800
+2% +$93.8K
FXI icon
6
CALL
iShares China Large-Cap ETF
FXI
$4.6B
$3.26M 2.16%
90,800
-17,200
-16% -$654K
INVA icon
7
Innoviva
INVA
$1.6B
$2.85M 1.89%
122,402
+116,863
+2,110% +$2.52M
FEMY icon
8
Femasys
FEMY
$9.09M
$2.54M 1.68%
301,652
+5,057
+2% +$56.3K
TLSA icon
9
Tiziana Life Sciences
TLSA
$136M
$2.53M 1.68%
2,165,231
+405,449
+23% +$574K
AEON icon
10
AEON Biopharma
AEON
$7.76M
$2.49M 1.65%
2,527,775
+395,923
+19% +$443K
LINC icon
11
Lincoln Educational Services
LINC
$1.36B
$2.42M 1.6%
59,439
+3,416
+6% +$108K
JOE icon
12
St. Joe Company
JOE
$3.48B
$2.03M 1.34%
32,253
-10,461
-24% -$700K
COUR icon
13
CALL
Coursera
COUR
$1.59B
$1.89M 1.25%
+324,500
New +$2.03M
PROF
14
Profound Medical
PROF
$249M
$1.56M 1.03%
240,739
+165,162
+219% +$1.14M
TOI icon
15
The Oncology Institute
TOI
$535M
$1.42M 0.94%
+462,057
New +$1.42M
TROW icon
16
PUT
T. Rowe Price
TROW
$25.1B
$1.33M 0.88%
+14,800
New +$1.43M
QNRX
17
Quoin Pharmaceuticals
QNRX
$8.52M
$1.3M 0.86%
+196,592
New +$1.78M
PPC icon
18
Pilgrim's Pride
PPC
$6.93B
$1.19M 0.78%
+31,384
New +$1.27M
CALM icon
19
Cal-Maine
CALM
$4.2B
$1.13M 0.75%
+14,227
New +$1.17M
MPC icon
20
Marathon Petroleum
MPC
$91.3B
$1.01M 0.67%
4,156
-1,774
-30% -$358K
UNCY icon
21
Unicycive Therapeutics
UNCY
$147M
$968K 0.64%
147,087
+57,672
+64% +$378K
ARMP icon
22
Armata Pharmaceuticals
ARMP
$166M
$928K 0.61%
90,580
+84,449
+1,377% +$711K
MRX
23
Marex Group Limited Ordinary Shares
MRX
$4.33B
$906K 0.6%
20,322
-1,678
-8% -$66.3K
TRAW icon
24
Traws Pharma
TRAW
$10.2M
$763K 0.51%
+416,998
New +$784K
KZIA
25
Kazia Therapeutics
KZIA
$152M
$594K 0.39%
79,832
+79,831
+7,983,100% +$556K

Similar funds

Dauntless Investment Group's Q1 2026 Portfolio in Review

As of Q1 2026, Dauntless Investment Group held 96 positions worth $151M, up 20% from $126M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Dauntless Investment Group deployed $25M of net new capital in Q1 2026, opening 30 new positions and adding to 14 existing holdings. Its largest new stake was Quoin Pharmaceuticals: 196,592 shares worth $1.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 7.9% a quarter earlier, followed by Consumer Staples and Real Estate.

On the sell side, the largest reduction was Adecoagro, an estimated $1.68M trimmed.

  • Dauntless Investment Group's largest Q1 2026 buy was Quoin Pharmaceuticals: 196,592 shares worth $1.3M.
  • Dauntless Investment Group added most to Innoviva in Q1 2026, an estimated $2.52M increase.
  • Dauntless Investment Group's biggest Q1 2026 reduction was Adecoagro, cutting an estimated $1.68M.
  • Dauntless Investment Group fully exited iShares MSCI South Korea ETF in Q1 2026, selling an estimated $919K.
  • Dauntless Investment Group's ten largest holdings make up 81% of its $151M portfolio in Q1 2026.
  • Dauntless Investment Group opened 30 new positions and closed 27 in Q1 2026.
  • Dauntless Investment Group's portfolio value rose 20% quarter-over-quarter to $151M.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.